CNS and Neurological Disorders - Drug Targets
短名 | CNSNDDT |
Journal Impact | 2.68 |
国际分区 | PHARMACOLOGY & PHARMACY(Q2) |
期刊索引 | SCI Q3中科院 4 区 |
ISSN | 1871-5273, 1996-3181 |
h-index | 96 |
国内分区 | 医学(4区)医学神经科学(4区)医学药学(4区) |
目标和范围CNS 和神经系统疾病 - 药物靶标旨在涵盖与神经和中枢神经系统 (CNS) 疾病有关的当代分子靶标的药物化学、药理学、分子生物学、基因组学和生物化学方面的所有最新和杰出的发展,例如:疾病特异性蛋白质、受体、酶、基因。CNS 和神经系统疾病 - 药物靶点发表客座编辑的主题问题,由该领域的领导者撰写,涵盖当前的中枢神经系统和神经药物靶点主题。该杂志还接受发表原创研究文章、信件、评论和药物临床试验研究。这本杂志是所有参与药物发现和开发的药物科学家的必备读物。
期刊主页投稿网址涉及主题 | 医学生物内科学心理学神经科学化学生物化学遗传学病理内分泌学精神科疾病药理学受体免疫学物理细胞生物学有机化学 |
出版信息 | 出版商: Bentham Science Publishers,出版周期: Bimonthly,期刊类型: journal |
基本数据 | 创刊年份: 2006,原创研究文献占比: 33.33%,自引率:3.70%, Gold OA占比: 0.72% |
平均审稿周期 | 网友分享经验:较慢,6-12周 |
平均录用比例 | 网友分享经验:较难 |
期刊引文格式
这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Amelioration of Neurochemical Alteration and Memory and Depressive Behavior in Sepsis by Allopurinol, a Tryptophan 2,3-Dioxygenase Inhibitor
2024-12-1
Association between Frequency of Seizures and Number of Antiseizure Medications (ASM) in Patients with Epilepsy
2024-12-1
Neurotrophin-3 Rescues Striatal Synaptic Plasticity in Model of Neurodegeneration by PLC Signaling Activation
2024-12-1
Pharmacogenetics of Carbamazepine: A Systematic Review on CYP3A4 and CYP3A5 Polymorphisms.
2024-12-1
Obesity and Depression: Common Link and Possible Targets
2024-12-1
GFAP and UCHL1 in Non-traumatic SAH: The Story thus Far. A Systematic Review of the Literature
2024-11-1
Flow Diversion for the Management of Posterior Circulation’s Intracranial Aneurysms
2024-11-1
The Landscape of Randomized Clinical Trial Meta-analyses on Statins for Aneurysmal Subarachnoid Hemorrhage: A Scoping Review
2024-11-1
Natural Compounds as Inhibitors of Aβ Peptide and Tau Aggregation
2024-10-1
LRRK2; Communicative Role in the Treatment of Parkinson’s Disease and Ulcerative Colitis Overlapping
2024-10-1
Application of Nanocomposites and Nanoparticles in Treating Neurodegenerative Disorders
2024-10-1
The Possible Protective Effect of Taurine on Bisphenol: Induced Structural Changes on the Cerebral Cortex of Rats: Histological and Immunohistochemical Study
2024-10-1
The Use of Midazolam as an Antiseizure Medication in Neonatal Seizures: Single Center Experience and Literature Review
2024-10-1
Towards a Systemic Concept of the Brain Ishemia Stroke: Monte Carlo Driven in silico Model
2024-10-1
Potential Neuroprotective Role of Neurotrophin in Traumatic Brain Injury
2024-10-1
Nadolol Attenuates Brain Cell Ferroptosis in Ischemic Stroke Rats by Targeting the HOIL-1/IRP2 Pathway
2024-9-9
Sleep-Related Disorders in Parkinson's Disease: Mechanisms, Diagnosis, and Therapeutic Approaches
2024-9-5
Neurotrophins in Peripheral Neuropathy: Exploring Pathophysiological Mechanisms and Emerging Therapeutic Opportunities
2024-9-5
Noninvasive Therapies: A Forthcoming Approach to Parkinson's Treatment
2024-9-2
Metabolic Disorder Therapeutics and their Effects on Memory
2024-9-1
Circadian Rhythms and Sleep Disorders Associated to Major Depressive Disorder: Pathophysiology and Therapeutic Opportunities
2024-9-1
The Essential Role of Astrocytes in Neurodegeneration and Neuroprotection
2024-9-1
Nordihydroguaiaretic Acid Affects Undifferentiated and Differentiated Neuroblastoma Cells Differently through Mechanisms that Impact on Cell Viability
2024-9-1
Role of Imaging Genetics in Alzheimer’s Disease: A Systematic Review and Current Update
2024-9-1
Anti-seizure Medications: Challenges and Opportunities
2024-9-1
Transdermal Therapeutic Systems for the Treatment of Alzheimer's Disease: A Patent Review
2024-9-1
Exerkines: A Crosstalk between Lactate Production, Exercise and Mental Health
2024-9-1
Amyotrophic Lateral Sclerosis (ALS): An Overview of Genetic and Metabolic Signaling Mechanisms
2024-8-21
Exploring the Pharmacological Effects of Bioactive Peptides on Human Nervous Disorders: A Comprehensive Review
2024-8-9
Deciphering the Role of Peroxisome Proliferator-activated Receptor α and Phosphodiesterase Type 5 Targets in Alzheimer's Disease
2024-8-1
Role of BDNF signaling in the neuroprotective and memory-enhancing effects of flavonoids in Alzheimer’s Disease
2024-8-1
Memory Reflections of the Microbiota-Gut and Oligodendrocyte Axis
2024-8-1
Montelukast Ameliorates Scopolamine-induced Alzheimer’s Disease: Role on Cholinergic Neurotransmission, Antioxidant Defence System, Neuroinflammation and Expression of BDNF
2024-8-1
Artificial Intelligence in The Management of Neurodegenerative Disorders
2024-8-1
The Effectiveness of Transcranial Magnetic Stimulation in Treating Apraxia
2024-8-1
Phosphodiesterase 2 and Its Isoform a as Therapeutic Targets in the Central Nervous System Disorders
2024-8-1
Neurological Manifestations Following Traumatic Brain Injury: Role of Behavioral, Neuroinflammation, Excitotoxicity, Nrf-2 and Nitric Oxide
2024-7-30
Neuroprotective Efficacy and Complementary Treatment with Medicinal Herbs: A Comprehensive Review of Recent Therapeutic Approaches in Epilepsy Management
2024-7-26
An Overview of the Natural Neuroprotective Agents for the Management of Cognitive Impairment Induced by Scopolamine in Zebrafish (Danio rerio)
2024-7-19
Glia as a New Target for Therapeutic Actions of Electroconvulsive Therapy
2024-7-12
The Gut Microbiota-Brain Axis: A New Frontier in Alzheimer's Disease Pathology
2024-7-4
Acknowledgements to Reviewers
2024-7-3
Synchronized Glioma Insights: Trends, Blood Group Correlations, Staging Dynamics, and the Vanguard of Liquid Biopsy Advancements
2024-7-2
Electrolyte Imbalance and Neurologic Injury
2024-7-1
Therapeutic Potential of Myricetin in the Treatment of Neurological, Neuropsychiatric, and Neurodegenerative Disorders
2024-7-1
Neuroprotection or Sex Bias: A Protective Response to Traumatic Brain Injury in the Females
2024-7-1
Oxidative Stress and Dopaminergic Metabolism: A Major PD Pathogenic Mechanism and Basis of Potential Antioxidant Therapies
2024-7-1
Navigated Transcranial Magnetic Stimulation (nTMS) based Preoperative Planning for Brain Tumor Treatment
2024-7-1
Casein Kinase 2 Affects Epilepsy by Regulating Ion Channels: A Potential Mechanism
2024-7-1
Evolutionary Unmasking Resuscitative Therapeutics Potential of Centhaquin Citrate in Hypovolemic Shock
2024-7-1
帮你贴心管理全部的文献
研飞ivySCI,高效的论文管理
投稿经验分享
分享我的经验,帮你走得更远